Experimental drug may slow dementia onset for patients with rare genetic form of Alzheimer’s The drug targets amyloid plaques that build up in the brain years before symptoms appear. Euronews · Mar 20, 2025
New drug could reduce risk of early-onset Alzheimer’s disease The results boost hopes similar treatments being developed to target more common forms of Alzheimer's - that appear when people reach their sixties, seventies and eighties - might also be effective. The Independent UK · Mar 20, 2025
Researchers find a hint at how to delay Alzheimer's symptoms. Now they have to prove it An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at a young age The Independent UK · Mar 19, 2025
Blood tests can help diagnose Alzheimer's — if they're accurate enough. Not all are A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests. WEKU · Jan 11, 2024
Lisa Jarvis: That blockbuster Alzheimer’s drug? It’s not a cure Biogen Inc. and Eisai Co. caused a stir in September when they announced positive results in a late-stage trial for a closely watched Alzheimer’s drug, lecanemab. Doctors tempered their excitement, though, until they could scrutinize the full peer-reviewed data. Tribune News Service · Dec 1, 2022
What causes Alzheimer's? Study puts leading theory to 'ultimate test' Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. WEKU · Nov 1, 2022